Ablation of Inappropriate Sinus Tachycardia: A Systematic Review of the Literature

JACC. Clinical Electrophysiology
Moisés Rodríguez-MañeroMiguel Valderrábano

Abstract

The goal of this study was to describe short- and long-term outcomes in all patients referred for inappropriate sinus tachycardia ablation, along with the potential complications of the intervention. Sinus node (SN) ablation/modification has been proposed for patients refractory to pharmacological therapy. However, available data derive from limited series. The electronic databases MEDLINE, Embase, CINAHL, Cochrane, and Scopus were systematically searched (January 1, 1995-December 31, 2015). Studies were screened according to predefined inclusion and exclusion criteria. A total of 153 patients were included. Their mean age was 35.18 ± 10.02 years, and 139 (90.8%) were female. All patients had failed to respond to maximum tolerated doses of pharmacological therapy (3.5 ± 2.4 drugs). Mean baseline heart rates averaged 101.3 ± 16.4 beats/min according to electrocardiography and 104.5 ± 13.5 beats/min according to 24-h Holter monitoring. Two electrophysiological strategies were used, SN ablation and SN modification, with the latter being used more. Procedural acute success (using variably defined pre-determined endpoints) was 88.9%. Consistently, all groups reported high-output pacing from the ablation catheter to confirm absence o...Continue Reading

References

Feb 17, 2000·Journal of the American College of Cardiology·K C ManF Morady
Mar 19, 2002·Journal of the American College of Cardiology·Nassir F MarroucheAndrea Natale
Mar 12, 2004·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Chad E BonhommeSteve S Hsu
May 9, 2008·Journal of Cardiovascular Electrophysiology·Brian Olshansky
Jul 14, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Leonardo CalòFrancesco Fedele
Sep 23, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·Stephan ZellerhoffStefan Kääb
Mar 28, 2012·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Ammar M KilluSamuel J Asirvatham
Jul 10, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Pawel PtaszynskiJerzy K Wranicz
Dec 26, 2012·Journal of the American College of Cardiology·Brian Olshansky, Renee M Sullivan
Nov 19, 2013·Journal of Cardiovascular Electrophysiology·Jason T JacobsonJeffrey J Goldberger
Jan 26, 2016·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Sergio Hugo Ibarra-CortezMiguel Valderrábano

❮ Previous
Next ❯

Citations

Jun 22, 2019·Journal of Cardiovascular Electrophysiology·Seyed Hossein Aalaei-AndabiliThomas M Beaver
Jan 14, 2020·Journal of the American Heart Association·Hiroshige Yamabe, Yoshiya Orita
Jun 23, 2018·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Brian Olshansky, Renee M Sullivan
Nov 13, 2020·Journal of Cardiovascular Electrophysiology·Khalil El Gharib
Jan 8, 2021·Current Problems in Cardiology·Ikechukwu IfediliRami Khouzam
Jan 30, 2021·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·G GarretN Saoudi
Feb 11, 2021·Journal of Cardiovascular Electrophysiology·Samuel A ShabtaieSamuel J Asirvatham
Jun 4, 2021·Circulation Journal : Official Journal of the Japanese Circulation Society·Akihiko NogamiUNKNOWN JCS/JHRS Joint Working Group
May 25, 2021·HeartRhythm Case Reports·Atif AlQubbanyJohn Silberbauer
Aug 3, 2021·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Jose Carlos Pachon-M, Enrique I Pachon-M
Aug 14, 2021·Journal of Arrhythmia·Akihiko NogamiUNKNOWN JCS/JHRS Joint Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.